Literature DB >> 4356047

Studies relating to the antihypertensive and antidysrhythmic action of indoramin.

T Baum, A T Shropshire, D K Eckfeld, N Metz, J L Dinish, J R Peters, F Butz, M I Gluckman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4356047

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


× No keyword cloud information.
  5 in total

1.  Cardiovascular effects of indoramin in man--a dose ranging study.

Authors:  D P Nicholls; D W Harron; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

Review 2.  Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.

Authors:  B Holmes; E M Sorkin
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

3.  Improvement in angina pectoris with alpha adrenoceptor blockade.

Authors:  P Collins; D Sheridan
Journal:  Br Heart J       Date:  1985-05

4.  Investigation into the cardioregulatory properties of the alpha 1-adrenoceptor blocker indoramin.

Authors:  V Pierce; N B Shepperson; M H Todd; J F Waterfall
Journal:  Br J Pharmacol       Date:  1986-02       Impact factor: 8.739

5.  Indoramin-prolongation of repolarization time, a mechanism of bradycardia in man?

Authors:  D W Harron; D P Nicholls; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.